Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1982;65:27-32

This Article
Right arrow Order Full text via Infotrieve
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rosati, R. A.
Right arrow Articles by Harrell, F. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rosati, R. A.
Right arrow Articles by Harrell, F. E., Jr

Circulation, Vol 65, 27-32, Copyright © 1982 by American Heart Association


ARTICLES

Problems and advantages of an observational data base approach to evaluating the effect of therapy on outcome

RA Rosati, KL Lee, RM Califf, DB Pryor and FE Harrell Jr

In this report, we summarize the strengths and problems of an observational data base approach to evaluating therapy and studying patient outcomes in long-term chronic disease. Because this approach includes a greater spectrum of patients than randomized clinical trials, it offers a definite advantage with regard to the elucidation of prognostic factors and the application of results to specific patients. The major difficulty with the observational data base approach is that the important prognostic factors must be known for treatment comparisons to be valid. Both the observational data base and randomized trial approaches are susceptible to criticism because the multiple comparisons and multiple experiments usually involved make the results of any one study not definitive. Either approach is useful in generating or confirming a hypothesis about particular subgroups. Regardless of the method used, proof that a particular therapy increases survival in any group or subgroup of patients with coronary artery disease usually requires confirmation by multiple studies. Finally, observational data base approach, because it capitalizes on data generated and paid for in the patient care process, offers the most feasible approach for evaluating whether changes in prognosis are occurring over time and whether such changes are independent of the mix of the patient population.


This article has been cited by other articles:


Home page
ANN INTERN MEDHome page
R. A. MILLER, K. F. SCHAFFNER, and A. MEISEL
Ethical and Legal Issues Related to the Use of Computer Programs in Clinical Medicine
Ann Intern Med, April 1, 1985; 102(4): 529 - 536.
[Abstract] [PDF]